共 50 条
- [1] Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 650S - 650SMcCleod, MTreat, JChristiansen, NPMintzer, DMBonomi, PBloss, LPTaylor, LMonberg, MJYe, ZObasaju, CK
- [2] Front line therapy with gemcitabine(G) administered immediately prior to pemetrexed (P) for patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Final report of a phase II clinicalJOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 393S - 393SWest, H. J.Belt, R. J.Wakelee, H. A.Monberg, M. J.Frye, L. A.Ye, Z.Obasaju, C. K.
- [3] A PHASE II TRIAL OF PEMETREXED (P), GEMCITABINE (G), AND BEVACIZUMAB (BV) IN UNTREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1235Wozniak, AntoinetteKalemkerian, GregoryGadgeel, Shirish M.Ramnath, NithyaSchneider, BryanValdivieso, ManuelSmith, DarynHackstock, DeborahChen, WeiRuckdeschel, John
- [4] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Wozniak, A. J.Kalemkerian, G. P.Gadgeel, S. M.Schneider, B. J.Valdivieso, M.Venkatramanamoorthy, R.Hackstock, D. M.Chen, W.Heilbrun, L. K.Ruckdeschel, J. D.
- [5] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S454 - S454Wozniak, Antoinette J.Kalemkerian, Gregory P.Gadgeel, Shirish M.Schneider, Bryan J.Valdivieso, ManuelSmith, DarynHackstock, Deborah M.Chen WeiHeilbrun, Lance K.Ruckdeschel, John D.
- [6] Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trialANNALS OF ONCOLOGY, 2009, 20 (05) : 850 - 856West, H. L.Wakelee, H. A.Perry, M. C.Belt, R. J.Chen, R.Obasaju, C.
- [7] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trialJOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637SJanne, PASimon, GRLanger, CJTaub, RNDowlati, AFidias, PBloss, LPYe, ZObasaju, CKindler, HL
- [8] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trialLUNG CANCER, 2005, 49 : S282 - S282Janne, PSimon, GLanger, CTaub, RDowlati, AFidias, PBloss, LYe, ZObasaju, CKindler, H
- [9] Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 648S - 648STreat, JMcCleod, MMintzer, DChristiansen, NBonomi, PMonberg, MTaylor, LObasaju, C
- [10] Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trialLUNG CANCER, 2006, 53 (01) : 77 - 83Treat, JosephBonomi, PhilipMcCleod, MichaelChristiansen, Neal P.Mintzer, David M.Monberg, Matthew J.Ye, ZhishenChen, RuqinObasaju, Coleman K.